- Scientists & Nobel Prize-Winners
- Patients & Patient Groups
- Research Institutions & Libraries
- U.S. Congress
- U.S. Federal Agencies
- International Copyright Attorneys
Published Feb 6, 2007
For Immediate Release
February 6, 2007
Major society publisher announces support for public access to scientific literature
Washington, DC (Feb. 6, 2007) - The American Society for Cell Biology (ASCB), a non-profit scientific society of over 11,000 members and publisher of the high-impact monthly journal, Molecular Biology of the Cell, has announced its "Position on Public Access to Scientific Literature," calling for free public access to federally funded research within six months of publication. ASCB has provided free access (after a two-month embargo) to research published in its journals since 2001 and has experienced no adverse impact on its finances.
The ASCB statement, which was announced in a January 31, 2007 press release, reads:
ASCB Position on Public Access to Scientific Literature
The ASCB believes strongly that barriers to scientific communication slow scientific progress. The more widely scientific results are disseminated, the more readily they can be understood, applied, and built upon. The sooner findings are shared, the faster they will lead to new scientific insights and breakthroughs. This conviction has motivated the ASCB to provide free access to all of the research articles in Molecular Biology of the Cell two months after publication, which it has done since 2001. The articles are available both on the journal’s website and in the National Library of Medicine’s online archive, PubMed Central.
The vast majority of the biomedical research conducted at American universities and colleges is funded by taxpayers. The ASCB believes that taxpayers are best served when all scientists, educators, physicians, and members of the public - including patients and their families - have access to publicly funded research results. So long as significant access barriers remain, taxpayers are not fully benefiting from the work that they fund. With the proliferation of networked technology, we have an unprecedented and cost-effective means to overcome such barriers. For the first time, it is possible and practical to offer free access to every potential user. It is incumbent upon us, as scientists and citizens, to take full advantage of this opportunity.
Some publishers argue that providing free access to their journal’s content will catastrophically erode their revenue base. The experience of many successful research journals demonstrates otherwise; these journals make their online content freely available after a short embargo period that protects subscription revenue. For example, as noted above, the content of Molecular Biology of the Cell is free to all after only two months, yet the journal remains not only financially sound, but profitable. The data clearly show that free access and profitability are not mutually exclusive.
Our goal should be to make research articles freely available as soon as feasible so that science and the public benefit from their expanded use and application. At the same time, it is important that nonprofit societies and other publishers generate sufficient revenues to sustain the costs of reviewing and publishing articles. We believe that a six-month embargo period represents a reasonable compromise between the financial requirements of supporting a journal and the need for access to current research.
For these reasons, the ASCB supports efforts to require that the results of federally funded biomedical research be made freely available to the public, no more than six months after they are published.
The statement, which is available online at http://ascb.org/index.cfm?navid=10&id=1968&tcode=nws3, bolsters the case for a mandatory National Institutes of Health public access policy and for passage of The Federal Research Public Access Act, a measure that would require federal agencies that fund over $100 million in annual external research to make manuscripts of peer-reviewed journal articles stemming from that research publicly available via the Internet within six months of publication. The bill was introduced last year by Senator John Cornyn (R-TX) and Senator Joseph Lieberman (I-CT) and awaiting reintroduction in the 110th Congress (For further information about the legislation, see http://www.taxpayeraccess.org/issues/frpaa/federal-research-public-access-act.shtml).
The Alliance for Taxpayer Access is a coalition of patient, academic, research, and publishing entities that support open public access to the results of federally funded research, including passage of the Federal Research Public Access Act. The Alliance was formed in 2004 to urge that peer-reviewed articles on taxpayer-funded research become fully accessible and available online at no extra cost to the American public. Details on the ATA may be found at http://www.taxpayeraccess.org.